Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 3
1965 1
1973 1
1974 7
1975 40
1976 68
1977 95
1978 61
1979 99
1980 93
1981 80
1982 105
1983 124
1984 109
1985 83
1986 105
1987 69
1988 72
1989 60
1990 76
1991 76
1992 65
1993 86
1994 93
1995 82
1996 97
1997 89
1998 80
1999 117
2000 129
2001 146
2002 151
2003 176
2004 176
2005 175
2006 162
2007 209
2008 201
2009 189
2010 215
2011 247
2012 217
2013 189
2014 202
2015 224
2016 171
2017 146
2018 151
2019 126
2020 151
2021 131
2022 89
2023 46
2024 84

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,648 results

Results by year

Filters applied: . Clear all
Page 1
Fludarabine: a review.
Hood MA, Finley RS. Hood MA, et al. DICP. 1991 May;25(5):518-24. doi: 10.1177/106002809102500512. DICP. 1991. PMID: 2068837 Review.
Cytarabine is used principally as an antileukemic agent, and vidarabine as an antiviral. Unlike vidarabine, fludarabine is resistant to deactivation by adenosine deaminase. ...
Cytarabine is used principally as an antileukemic agent, and vidarabine as an antiviral. Unlike vidarabine, fludarabine is res …
Vidarabine (Vira-A).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1977 May 20;19(10):42-3. Med Lett Drugs Ther. 1977. PMID: 323676 Clinical Trial. No abstract available.
Vidarabine is neither a potent nor a selective AC5 inhibitor.
Seifert R. Seifert R. Biochem Pharmacol. 2014 Feb 15;87(4):543-6. doi: 10.1016/j.bcp.2013.12.025. Epub 2014 Jan 4. Biochem Pharmacol. 2014. PMID: 24398424 Review.
Therefore, vidarabine has been suggested to mediate these effects via selective inhibition of AC5. Based on these results, clinical studies with vidarabine in humans for heart failure and cancer have been proposed. Here, evidence is presented that vidarabine …
Therefore, vidarabine has been suggested to mediate these effects via selective inhibition of AC5. Based on these results, clinical s …
Vidarabine ophthalmic ointment (Vira-A).
[No authors listed] [No authors listed] Drug Ther Bull. 1979 May 25;17(11):43-4. Drug Ther Bull. 1979. PMID: 467237 No abstract available.
Oral fludarabine.
Plosker GL, Figgitt DP. Plosker GL, et al. Drugs. 2003;63(21):2317-23. doi: 10.2165/00003495-200363210-00004. Drugs. 2003. PMID: 14524733 Review.
Vidarabine encephalopathy.
Cullis PA, Cushing R. Cullis PA, et al. J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1351-4. doi: 10.1136/jnnp.47.12.1351. J Neurol Neurosurg Psychiatry. 1984. PMID: 6512557 Free PMC article.
Vidarabine (adenine arabinoside, ara-a) has been found to be useful in the treatment of various viral infections. Its adverse neurological effects include tremor and encephalopathy. Two cases of vidarabine encephalopathy are reported and the five other cases in the …
Vidarabine (adenine arabinoside, ara-a) has been found to be useful in the treatment of various viral infections. Its adverse neurolo …
Fludarabine.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1991 Sep 20;33(853):89-90. Med Lett Drugs Ther. 1991. PMID: 1886506 No abstract available.
5,648 results